Free accessResearch articleFirst published online 1990-2
Double-Blind Study of the Reversal of Midazolam-Induced Sedation in the Intensive Care Unit with Flumazenil (Ro 15–1788): Effect on Weaning from Ventilation
Midazolam (0.1–0.2 mg/kg/hr) and morphine (2 mg/hr) were given by carefully regulated continuous intravenous infusions to thirty patients who required sedation, analgesia and ventilation for between twelve and twenty-four hours in the Intensive Care Unit. The midazolam and morphine infusions were stopped at the end of the period of sedation required and the efficacy of placebo or flumazenil in reversing the sedative effects of midazolam was compared in this double-blind randomised parallel group study.
Patients receiving flumazenil were less sedated (P < 0.05), able to obey commands (P < 0.05), weaned from ventilation (P < 0.05) and extubated (P < 0.05) significantly earlier than those receiving placebo.
GellerE., HalpernP., LeykinY., RudickV., SorkineP.Midazolam infusion and benzodiazepine antagonist for sedation in ICU. Anesthesiology1986; 65: 49A.
2.
MichalkS., MonlorgeC., FichelleA., FarinottiR., DeemontsJ.M.Long term midazolam infusion for basal sedation in ITU. Anesthesiology1986; 65: A66.
3.
BehneM., AsskaliF., SteverA., FosterH.Continuous infusion of midazolam for sedation of ventilated patients. Anaesthetist1987; 36: 228–232.
4.
MatthewsH.M.L., CarsonI.W., CollierP.S.Midazolam sedation following open heart surgery. Br J Anaesth1987; 59: 557–560.
5.
O'DeaJ., HopkinsonR.Alfentanil — midazolam infusion. Care Crit Ill.1987; 3: 20–21.
6.
BookerP.D., BeecheyA., Lloyd ThomasA.R.Sedation of children requiring ventilation using an infusion of midazolam. Br J Anaesth1986; 58: 1104–1108.
7.
BionJ.F.Sedation and analgesia in the ICU. Hospital Update1988; 14: 1272–1286.
8.
DundeeJ.W., SamuelI.O., TonerW., HowardP.J.Midazolam: a water soluble benzodiazepine. Anaesthesia1980; 35: 454–8.
9.
HaefelyW., KulcsarA., MohlerH., PieriL., PolcP., SchaffnerR.In: Costa E, Greengard P, Eds. Mechanism of action of benzodiazepines. Raven Press, New York; 1975: 131–53.
10.
CostaE., GuidottiA., MaoC.C. In: RobertsE., ChaseT.N. eds. GABA in nervous system function.Raven Press, New York; 1976: 413–426.
11.
MohlerH., OkadaT.Benzodiazepine receptor: demonstration in the central nervous system. Science1977; 198: 849–851.
12.
BraestrupC., SquiresR.F.Specific benzodiazepine receptors in rat brain characterised by high affinity 3H — diazepam binding. Proc Nat Acad Sci U.S.A.1977; 74: 3805–9.
13.
HunkelerW., MohlerH., PieriL.Selective antagonists of benzodiazepine. Nature1981; 290: 514–516.
14.
AlonE., BaitellaL., HossliG.Double blind study of the reversal of midazolam supplemented general anaesthetic with Ro 15-1788. Br J Anaesth1987; 59: 455–458.
LouisM., ForsterA., SuterP.M., GempergeM.Clinical and haemodynamic effects of a specific benzodiazepam antagonist (Ro 15-1788) after open heart surgery. Anesthesiology1984; 61: 61.
17.
GellerE., SilbigerA., NivD., NevoY., BelhassenB.The reversal of benzodiazepine sedation with Ro 15-1788 in brief procedures. Anesthesiology1986; 65: A357.
18.
SageD.J., CloseA., BoasR.A.Reversal of midazolam sedation with anexate. Br J Anaesth1987; 59: 459–464.
19.
RodrigoR.C., RosenquistJ.B.The effect of Ro 15-1788 (Anexate) on conscious sedation produced with midazolam. Anaesth Intens Care1987; 15: 185–192.
20.
GellerE., HalpernP., LeykinY., RuddickV., SorkineP.Midazolam infusion and benzodiazepine antagonist for sedation in ICU. Anesthesiology1986; 65: 49A.
21.
KleinbergerG., GrimmG., LaggnerA., DrumlW., LenzK.Weaning patients from mechanical ventilation by benzodiazepine antagonist Ro 15–1788. Lancet1985; ii: 268–9.
22.
BionJ., LedinghamI McA. Sedation in intensive care. Intens Care Med1987; 13: 215–6.
23.
GastP.H., FisherA., SearJ.W.Intensive care sedation now. Lancet1984; ii: 863–4.
24.
Anonymous.Sedation in the Intensive Care Unit. (Editorial) Lancet1984; i: 1388–9.
25.
McQuayH., MooreA.Be aware of renal function when prescribing morphine. Lancet1984; iii: 284–5.
26.
DundeeJ.W., HallidayN.J., HarperK.W., BrogdenR.N.Midazolam: a review of its pharmacological properties and therapeautic uses. Drugs1984; 28: 519–543.
RoncariG., ZieglerW.H., GuentertT.W.Pharmacokinetics of the new benzodiazepine antagonist Ro 15-1788 in man following intravenous and oral administration. Bri J Clin Pharmacol1986; 22: 421–8.
33.
KlotzU., KantoJ.Pharmacokinetics and clinical use of flumazenil (Ro 15-1788). Clin Pharmacokinet1988; 14: 1–12.
